Download PDF
Thromb Haemost 1997; 77(01): 213-214
DOI: 10.1055/s-0038-1655932
Letter to the Editor
Schattauer GmbH Stuttgart

The 10-Base-Pair Insertion in the Promoter of the Factor VII Gene Is not Associated with Lower Levels of Factor VI Ic in Afrocarribeans

Anne Temple
1   The University College London, Department of Medicine, The Rayne Institute, London
,
Le Ahn Luong
1   The University College London, Department of Medicine, The Rayne Institute, London
,
Kennedy Cruickshank
2   Clinical Epidemiology Unit, University of Manchester Medical School, Manchester, UK
,
Steve E Humphries
1   The University College London, Department of Medicine, The Rayne Institute, London
› Author Affiliations
Further Information

Publication History

Received 06 June 1996

Accepted after revision 23 September 1996

Publication Date:
11 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Rapaport SI, Rao LVM. Initiation and regulation of tissue factor-dependent blood coagulation. Thrombosis Council Distinguished Lecture. Arterioscler Thromb 1992; 02: 111-121
    PubMedGoogle Scholar
  • 2 Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 02: 533-537
    PubMedGoogle Scholar
  • 3 Heinrich J, Balleisen L, Schulte H, Assmann G, van de LooJ. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 1994; 14: 54-59
    CrossrefPubMedGoogle Scholar
  • 4 Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: 1076-1079
    CrossrefPubMedGoogle Scholar
  • 5 Humphries SE, Lane A, Green FR, Cooper J, Miller GJ. Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration. Arterioscler Thromb 1994; 14: 193-198
    CrossrefPubMedGoogle Scholar
  • 6 Lane A, Cruickshank JK, Stewart J, Henderson A, Humphries S, Green F. Genetic and environmental determinants of factor VII coagulant activity in ethnic groups at differing risk of coronary heart disease. Atherosclerosis 1992; 94: 43-50
    CrossrefPubMedGoogle Scholar
  • 7 Kario K, Narita N, Matsuo T, Kayaba K, Tsutsumi A, Matsuo M, Miyata T, Shimada K. Genetic determinants of plasma FVII activity in the Japanese. Thromb Haemost 1995; 73: 617-622
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Arbini AA, Bauer KA. Reduced plasma factor VII coagulant activity due to the Arg353 gln polymorphism in the FII gene results from defective secretion. Blood 1994; 84: 86A (Abstract)
    PubMedGoogle Scholar
  • 9 Humphries S, Temple A, Lane A, Green F, Cooper J, Miller G. Low plasma levels of factor VIIc are associated with both glutamine 353 variant and a 10 base pair promoter (-323) insertion. Thromb Haemost 1996; 75: 567-572
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Bernardi F, Marchetti G, Pinotti M, Arcieri P, Baroncini C, Pappachini M, Zepponi E, Ursicino N, Chiarotti F, Mariani G. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler Thromb Vase Biol 1996; 16: 72-76
    PubMedGoogle Scholar
  • 11 Pollak ES, Hung H-L, Godin Willis, Overton GC, High KA. Functional characterisation of the human factor VII5’ flanking region. J Biol Chem 1996; 271: 1738-1747
    CrossrefPubMedGoogle Scholar